Academic User View: Organ-on-a-Chip Technology

Biosensors (Basel). 2022 Feb 16;12(2):126. doi: 10.3390/bios12020126.

Abstract

Organ-on-a-Chip (OoC) systems bring together cell biology, engineering, and material science for creating systems that recapitulate the in vivo microenvironment of tissues and organs. The versatility of OoC systems enables in vitro models for studying physiological processes, drug development, and testing in both academia and industry. This paper evaluates current platforms from the academic end-user perspective, elaborating on usability, complexity, and robustness. We surveyed 187 peers in 35 countries and grouped the responses according to preliminary knowledge and the source of the OoC systems that are used. The survey clearly shows that current commercial OoC platforms provide a substantial level of robustness and usability-which is also indicated by an increasing adaptation of the pharmaceutical industry-but a lack of complexity can challenge their use as a predictive platform. Self-made systems, on the other hand, are less robust and standardized but provide the opportunity to develop customized and more complex models, which are often needed for human disease modeling. This perspective serves as a guide for researchers in the OoC field and encourages the development of next-generation OoCs.

Keywords: disease models; drug testing; limitations; microphysiological systems (MPS); organ-on-a-chip (OoC); survey; usability.

MeSH terms

  • Drug Development*
  • Humans
  • Lab-On-A-Chip Devices*
  • Technology